Week 7 Flashcards

1
Q

Name 4 EPAs

A

Thermal
Non-thermal
Electrical stimulation
Othes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Thermal EPAs (7)

A
Hydrocollator (Hot) packs
Cryotherapy (Ice/cold/immersion)
Continuous Therapeutic Ultrasound
Shortwave Diathermy
Microwave Diathermy
Infrared 
Wax Bath
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Non thermal EPAs (8)

A
Pulsed ultrasound
Low intensity pulsed ultrasound (LIPUS))
Pulsed laser therapy
Pulsed shortwave therapy
Pulsed electromagnetic fields
Magnetic therapies
Mircrocurrent therapies
shock wave therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Electrical Stimulation EPAs (6)

A

Interferential therapy (IFT)
Transcutaneous Electrical Nerve stimulation (NMES)
Functional Electrical Stimulation (FES)
Microcurrent Therapy (MCT)
Transcranial Direct-Current Stimulation (tDCS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Other EPAs (4)

A

Biofeedback (no stimulation)
Electromyograph - Biofeedback
Ultrasound Imaging
Ultraviolet light

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pages to review

A

10,11.12, 25,26,33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Generation of US

A

An ultrasound wave is generated when an electric field is applied to an array of piezoelectric crystals located on the transducer surface. Electrical stimulation causes mechanical distortion of the crystals resulting in vibration and production of sound waves (i.e. mechanical energy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Generation of US Part 2

A

The conversion of electrical to mechanical (sound) energy is called converse piezoelectric effect (Gabriel Lippman 1881)

Frequency dependant on crystalline disc and current applied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Characteristics of Traditional US (3)

A

High frequency modality (1- 3MHz)
Thermal and non thermal effects
European, Antipodean North American approaches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Characteristics of Long Wave US (4)

A

Newer modality
45 kHz
Longer wavelength - penetrates more deeply (several metres)
promoted for same uses as traditional high frequency US

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a transducer

A

A device that produces sound waves that bounce off body tissues and make echoes. The transducer also receives the echoes and sends them to a computer that uses them to create a picture called a sonogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is ERA

A

Effective radiating arm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the power of US measured in

A

Watts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the intensity of US measured in

A

Wcm^-2

p20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Beam Non-uniformity Ratio (BNR)

A

Describes the consistency (or uniformity) of the US output ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does the BNR range from

A

10:1-2:1

Lower = better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the Duty Cycle (Pulsed Ratio)

A

describes the proportion of time the current is actually flowing
e.g. 5s on 10s off - duty cycle is 33% (1:2)
typically 1;1 or 1;4
each pulse lasts about 2ms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does frequency refer to

A

number of waves per second

19
Q

What is frequency measured in

A

Hertz (Hz)

20
Q

Do lower or higher frequencies penetrate further into the tissue?

A

Lower

21
Q

What are higher frequencies used for

A

Superficial tissue (3MHz)

22
Q

What are lower frequencies used for

A

Deeper tissue (1MHz)

23
Q

What is Attenuation

A

Reduction in energy as the ultrasonic wave passes through a medium
includes absorption, reflection, refraction and scattering

24
Q

Transducer/air percent reflection

A

99.9

25
Q

Soft tissue/air percent reflection

A

99.9

26
Q

Water / soft tissue percent reflection

A

0.2

27
Q

Soft tissue /fat percent reflection

A

1.0

28
Q

Soft tissue/bone percent reflection

A

15-40

29
Q

What is half depth

A

The depth in the tissues at which half the surface energy is available

30
Q

Half - value depth of penetration for muscle fat and tendon (1 and 3 MHz)

A
Muscle 1(9.0mm) 3(3.0
Fat 1(50mm) 3(16.5mm)
Tendon 1(6.2) 3(2.0)
3MHz = 2.0cm
1MHz = 4.0cm
31
Q

Therapeutic effects of thermal US

A

Increasing temperature (40-45 degrees )
hyperaemia, resolution of chronic
inflammatory states

32
Q

The effects of thermal US are dependant on what (4)

A

MODE of US continuous or pulsed
The vascularity of the tissue
Protein : fat content o the tissue (protein absorbs more than fat)
Frequency /intensity applied

33
Q

Tissues preferentially heated (7)

A
Periosteum
Superficial cortical bone
Joint menisci
fibrotic muscle
Tendon sheath
Major nerve roots
intermuscular interfaces
34
Q

Affects of therapeutic US on the inflammatory stage

A

Affects membrane potential
stimulates mast cells, platelets, white cells with phagocytic roles and the macrophages
Mast cell degranulation
Pro inflammatory not anti inflammatory

35
Q

Therapeutic US proliferative

A

Stimulation of fibroblasts, endothelial cells and myofibroblasts
Increased rate of angiogenesis
Increased protein and collagen synthesis
Proliferative - enhancing and maximising efficiency

36
Q

Therapeutic US during the Remodelling stage (3)

A

Enhancing normal deposition & organisation of collagen fibres
Enhancing tensile strength and scar tissue mobility
Effects are dependant on time of initial treatment

37
Q

Machine settings for US dose calculation

A

Machine frequency
Pulse ratio
intensity
time

38
Q

Other factors for US dose calculations

A

size of lesion
tissue state (stage of healing)
depth of lesion
half depth values

39
Q

US dose pages

A

38-40

40
Q

Contraindications of all EPAs (5)

A

Those who are unable to comprehend instructions, or who are unable to co-operate.
The application of EPAs over the abdomen, lower back or pelvis is normally contraindicated during the first 35-weeks of pregnancy.
In the area of a tumour where there is active or suspected malignancy, except for palliative care
Areas of recent bleeding tissue or haemorrhage
Active tuberculosis in treatment area

41
Q

Precautions for all EPAs (4)

A

Treatment should not normally be carried out:
Over the anterior aspect of the neck
When there is significant impairment in the circulation/sensory loss of the area to be treated
Where there is devitalised tissue e.g. recent radiotherapy
Where there is local acute skin conditions e.g eczema, dermatitis

42
Q

Contraindications for US

A

Avoid exposure to the developing foetus (i.e. do not treat over uterus during pregnancy)
Malignancies and precancerous lesions
Vascular abnormalities including DVT, severe arterio/atherosclerosis, emboli
Acute infections
Haemophiliacs not covered by factor replacement
Application over:
Eye • Testes • Stellate ganglion • Cardiac area in advanced heart disease/pacemakers • Spinal cord after laminectomy • Cranium • Active epiphyseal regions in children • Tissues previously treated by deep X-ray or other radiation

43
Q

Precautions for US (6)

A
  • Anaesthetic areas should be treated with caution if a thermal dose is being applied
  • Subcutaneous major nerves and bony prominences
  • Always use the lowest intensity which produces a therapeutic response
  • Ensure the applicator is moved throughout treatment
  • Ensure the patient is aware of the nature of the treatment and the expected effects
  • If pain, discomfort or unexpected sensations are experienced by the patient, the treatment intensity should be reduced. If the symptoms persist, the treatment should be terminated.